ÄÚÈÝ·¢²¼¸üÐÂʱ¼ä : 2026/3/23 14:30:44ÐÇÆÚÒ» ÏÂÃæÊÇÎÄÕµÄÈ«²¿ÄÚÈÝÇëÈÏÕæÔĶÁ¡£
¡¶GMPÓ¢Óï´Ê»ã¼°Ëõд¡·
µÚÒ»²¿·Ö
PIC/SµÄÈ«³ÆÎª£ºPharmaceutical Inspection Convention/Pharmaceutical Inspection Cooperation Scheme, PIC/S(ÖÆÒ©¼ì²é²Ý°¸), Ò©Æ·¼ì²éлá(PIC/S) ,Ò²ÓÐÈ˳ÆPIC/SΪҽҩÉó²é»áÒé/ºÏ×÷¼Æ»®£¨PIC/S£©
PICµÄȨÍþ·Ò룺ҩƷÉú²ú¼ì²éÏ໥³ÐÈϹ«Ô¼
API(Active Pharmaceutical Ingrediet) ÔÁÏÒ© Óֳƣº»îÐÔÒ©Îï×é·Ö AirLock ÆøÕ¢ Authorized Person ÊÚȨÈË Batch/Lot Åú´Î
Batch Number/Lot-Number ÅúºÅ£»Batch Numbering System Åú´Î±àÂëϵͳ£»
Batch Records Åú¼Ç¼£»Bulk Product ´ý°ü×°Æ·£»Calibration УÕý£»Clean area½à¾»Çø£»Consignmecnt£¨Delivery£©ÍÐÏúÒ©Æ·¡£
FDA£¨FOOD AND DRUG ADMINISTRATION£©£º£¨ÃÀ¹ú£©Ê³Æ·Ò©Æ·¹ÜÀí¾Ö IND£¨INVESTIGATIONAL NEW DRUG£©£ºÁÙ´²Ñо¿ÉêÇë
£¨Ö¸É걨½×¶Î,Ïà¶ÔÓÚNDA¶ø ÑÔ£©£»Ñо¿ÖеÄÐÂÒ©£¨Ö¸ÐÂÒ©¿ª·¢½×¶Î£¬Ïà¶ÔÓÚÐÂÒ©¶øÑÔ£¬¼´ÁÙ´²Ç°Ñо¿½áÊø£©
NDA£¨NEW DRUG APPLICATION£©£ºÐÂÒ©ÉêÇë
ANDA£¨ABBREVIATED NEW DRUG APPLICATION£©£º¼ò»¯ÐÂÒ©ÉêÇë TREATMENT IND£ºÑо¿ÖеÄÐÂÒ©ÓÃÓÚÖÎÁÆ ABBREVIATED£¨NEW£©DRUG£º¼ò»¯ÉêÇëµÄÐÂÒ© DMF£¨DRUG MASTER FILE£©£ºÒ©ÎïÖ÷Îļþ
£¨³ÖÓÐÕßΪ½÷É÷Æð¼û¶ø×¼±¸µÄ±£ÃÜ×ÊÁÏ£¬¿ÉÒÔ°üÀ¨Ò»¸ö»ò¶à¸öÈËÓÃÒ©ÎïÔÚÖÆ±¸¡¢¼Ó¹¤¡¢°ü×°ºÍÖü´æ¹ý³ÌÖÐËùÉæ¼°µÄÉ豸¡¢Éú²ú¹ý³Ì»òÎïÆ·¡£Ö»ÓÐÔÚDMF³ÖÓÐÕß»òÊÚȨ´ú±íÒÔÊÚȨÊéµÄÐÎʽÊÚȨ¸øFDA£¬FDAÔÚÉó²éIND¡¢ NDA¡¢ANDAʱ²ÅÄܲο¼ÆäÄÚÈÝ£© HOLDER£ºDMF³ÖÓÐÕß
CFR£¨CODE OF FEDERAL REGULATION£©£º£¨ÃÀ¹ú£©Áª°î·¨¹æ PANEL£º×¨¼ÒС×é
BATCH PRODUCTION£ºÅúÁ¿Éú²ú£»·ÖÅúÉú²ú BATCH PRODUCTION RECORDS£ºÉú²úÅúºÅ¼Ç¼
POST-OR PRE- MARKET SURVEILLANCE£ºÏúÊÛǰ»òÏúÊÛºó¼à¶½ INFORMED CONSENT£ºÖªÇéͬÒâ
£¨»¼Õß¶ÔÖÎÁÆ»òÊÜÊÔÕß¶ÔÒ½ÁÆÊÔÑéÁ˽âºó±íʾͬÒâ½ÓÊÜÖÎÁÆ»òÊÔÑ飩 PRESCRIPTION DRUG£º´¦·½Ò©
OTC DRUG£¨OVER¡ªTHE¡ªCOUNTER DRUG£©£º·Ç´¦·½Ò©
µÚ¶þ²¿·Ö GMPÎļþ³£¼ûËõд
ABPI Association of the British Pharmaceutical Industry ADR Adverse Drug Reaction AE Adverse Event
AIM Active Ingredient Manufacturer ANDA Abbreviated New Drug Application ANOVA Analysis of Variance ASM: Active Substance Manufacturer ATC Anatomical Therapeutic Chemical ATX Animal Test Exemption Certificate BAN British Approved Name
BIRA British Institute of Regulatory Affairs BNF British National Formulary BP British Pharmacopoeia C of A Certificate of Analysis C of S Certificate of Suitability
CENTRE FOR DRUG EVALUATION (CDE) Centre for Pharmaceutical Administration (CPA) CMS Concerned Member State CMSÿ¸ö³ÉÔ±¹ú
COS Certificate of Suitability
CPMP Committee for Proprietary Medicinal Products CRA Clinical Research Associate CRF Case Report Form
CRO Contract Research Organisation CTA Clinical Trial Application CTC Clinical Trial Certificate CTD Common Technical Document CTX Clinical Trials Exemption DDD Defined Daily Dose DGC Daily Global Comparison DIA Drug Information Association DMF Drug Master File
Drug Registration Branch (DR, Product Evaluation & Registration Division, CPA
EDQM (European Directorate for the Quality of Medicines) Å·ÖÞÁªÃËÒ©Æ·ÖÊÁ¿Ö¸µ¼Î¯Ô±»á EEA Å·ÖÞ¾¼ÃµØÇø
EGMA European Generics Medicine Association ELA Established Licence Application
EMEA European Medicines Evaluation Agency
EMEA £¨European Agency for the Evaluation of Medicinal Products£© Å·ÖÞÁªÃËÒ©Æ·ÆÀ¼Û»ú¹¹ EP European Pharmacopoeia
EPAR European Public Assessment Reports ESRA European Society of Regulatory Affairs European Pharmacopoeia Commission Å·ÖÞÒ©µäίԱ»á FDA
FDA Food and Drug Administration final evaluation report (FER) free sale certificates (FSCs) GCP Good Clinical Practice GCPÒ©Æ·ÁÙ´²Ñо¿¹ÜÀí¹æ·¶ GLP Good Laboratory Practice
GLP Ò©Æ·ÁÙ´²Ç°°²È«ÐÔÑо¿ÖÊÁ¿¹ÜÀí¹æ·¶ GMP Good Manufacturing Practice GMP Ò©Æ·Éú²úÖÊÁ¿¹ÜÀí¹æ·¶ GSPÒ©Æ·ÏúÊÛ¹ÜÀí¹æ·¶ Health Sciences Authority (HSA)
HSA¡¯s Medicines Advisory Committee (MAC) IB Investigators Brochure
ICH International Conference for Harmonisation IDMC Independent Data-Monitoring Committee IEC Independent Ethics Committee IND Investigational New Drug
INN International Non-proprietary Name International Conference on Harmonisation (ICH) IPC In Process Control IRB Institutional Review Board LICENCE HOLDER MA Marketing Authorisation
MAA Marketing Authorisation Application MAAÉÏÊÐÉêÇë
MAH Marketing Authorisation Holder